No "back to normal" after COVID-19 for our failed drug policies
No "back to normal" after COVID-19 for our failed drug policies
复制标题
DOI：
10.1016/j.drugpo.2020.102901
复制
发表时间：
2020-09-01
影响因子：
4.4
通讯作者：
Beletsky, Leo
中科院分区：
文献类型：
--
作者：
del Pozo, Brandon;Beletsky, Leo
在COVID-19大流行之前，倡导者长期以来一直敦促基于健康、安全、公民权利、种族正义、财政管理和其他考虑进行药物政策改革。在美国，这样的呼吁基本上没有得到回应。为应对COVID-19，公共卫生和职业安全问题迅速改变了一些药物政策，沿着这些政策的执行。几乎与此同时，全国范围内反对军事化警察的暴力和种族主义的抗议活动突出了毒品战争在助长监狱系统方面的持久遗产。这些历史事件的破坏提供了一个百年一遇的机会，重新考虑毒品政策和警察的法律的架构，无论是在美国还是其他地方。与其回到一个根本破碎和不公平的现状，我们敦促设想一个新的毒品政策，为生命，自由和追求幸福服务。
Before COVID-19 pandemic, advocates had long urged drug policy reforms based on health, security, civil rights, racial justice, fiscal stewardship, and other considerations. In the United States, such calls went largely unanswered. In response to COVID-19, public health and occupational safety concerns have rapidly transformed some drug policies, along with their enforcement. Almost contemporaneously, nationwide protests against violence and racism by militarized police have highlighted the enduring legacy of the Drug War in fueling carceral systems. Disruption from these historical events provides a once-in-a-century opportunity to reconsider the legal architecture of drug policy and policing-both in the U.S. and elsewhere. Rather than returning to a fundamentally broken and inequitable status quo, we urge envisioning a new drug policy in service to life, liberty, and the pursuit of happiness.